Adam Buchanan

A treat to work with @MarciLBSchwartz , @MiraHallquist , @AmyCurrySturm and the rest of the talented MyCode Genomic Screening & Counseling team on this one. Hope this is useful for other population genomic screening programs seeking to connect their patients to care.

Don’t miss Melissa Kelly's Platform Presentation today at 2:30pm-2:45pm, Room 714/16 #ACMGMtg24

Lots of great work from the talented Geisinger genomics team!

Exciting Genetic Counselor opportunity at Geisinger to join our multidisciplinary clinical and research team at Geisinger’s Autism & Developmental Medicine Institute (ADMI). Potential opportunity for role as team lead depending on background and experience. Interested candidates

Be sure to stop by Geisinger’s booth (#833) during the open exhibit hall hours to learn about our current open positions, opportunities for collaboration, and the exciting clinical and research genomic programs going on at Geisinger! #ACMgMtg24

Congratulations to Melissa Kelly, MS, CGC, Co-Director of the MyCode Genomic Screening and Counseling Program at Geisinger, for winning the Carolyn Lovett Award for Best Presentation by a Genetic Counselor!

We’re excited to see everyone at the #ACMGMtg24 Opening Reception! Be sure to visit Geisinger’s booth (#833) to meet our team and learn about current open positions, opportunities for collaboration, and the exciting clinical and research genomic programs going on at Geisinger!

Testing and Management of Iron Overload After Genetic Screening-Identified Hemochromatosis dlvr.it/SxrW9d

Perhaps FAP isn’t what we thought it was? Important work led by @RochaHeather and Rachel Schwiter showing we might need to think differently about whether and how to screen populations for pathogenic APC variants.

@HHampel1 @cityofhope Shoot! Hope your session went well.

@AdamBuchanan76 @cityofhope Are you kidding me - I can’t believe I missed you. I literally walked by to scope out my poster location!

Come visit me at poster 236 to see the clinical utility of @cityofhope Precision Medicine study among #LynchSyndrome patients. #ASCO23

@LaneyJonesRx @NHLBI_Translate @GeisingerRsrch @Marc_GeneDoc Incredible work that’ll find more people with FH and, we hope, decrease morbidity and mortality from coronary artery disease.

Today we enrolled our first site in our @NHLBI_Translate funded clinical trial to improve screening for familial hypercholesterolemia in primary care! Thanks to all the amazing people that have helped along the way @GeisingerRsrch @Marc_GeneDoc @AdamBuchanan76

@Marc_GeneDoc @GeisingerRsrch @MiraHallquist Thanks for pointing it out!

Great project. @GeisingerRsrch @AdamBuchanan76 @MiraHallquist please distribute internally if you haven't already.

@colleencaleshu Sorry about that! Just tweeted the full links - hope those work.

Highlighting two recent publications from our group on psych outcomes of receiving an actionable result from genomic screening in unselected healthcare system population: bit.ly/3OKemCB0, bit.ly/3VzQVy00. Take-home points:...1/4

Sorry - I exceeded my technical skill in attempting the bitly links. Here they are. ncbi.nlm.nih.gov/pmc/articles/P… and mdpi.com/2075-4426/12/1…

In other words, modest psych impact of results in this unselected population is consistent w/ response among those tested due to personal/family history. Kudos to, among others, @AmyCurrySturm @Alanna_Rahm @LaneyJonesRx @Marc_GeneDoc @MiraHallquist @gemmemc 4/4

And, most people adjust to the result using their typical support resources. Readily available risk management helped some people adjust. Finally, lessening engagement w/ the result over time could impact adherence to recommended risk management for the relevant diseases. 3/4

@kennedyborle @colleencaleshu @jamalenator @Alanna_Rahm @AmyCurrySturm @ElissaRLevin @hannah_wand Oh yay! @colleencaleshu, thanks for putting us up to it 😀!